CHARLENE JORDAN: Open Payments
NPI 1679800643 · CHRISTIANSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,442 in 63 payments from 31 companies in 2025. Trend: 2023 $1,190 · 2024 $2,492 · 2025 $2,442
Food & beverage: $1,218Long term medical supply or device loan: $1,000Education: $224
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $1,044 |
| Incyte Corporation | 4 | $252 |
| ABBVIE INC. | 4 | $222 |
| PFIZER INC. | 7 | $128 |
| Merck Sharp & Dohme LLC | 3 | $75 |
| Daiichi Sankyo Inc. | 3 | $71 |
| AstraZeneca Pharmaceuticals LP | 2 | $68 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Ipsen Biopharmaceuticals, Inc | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
Products named: KISQALI, JAKAFI, VENCLEXTA, ELREXFIO, IMBRUVICA, KEYTRUDA, Enhertu, DATROWAY.
Industry payments across VA — which companies pay providers there.
